Search
for
Sort by
Research 31–60 of 1000+
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood
- Estrus, ovulation, and serum progesterone, estradiol, and LH concentrations in mares after an increased photoperiod during winter.
- Quercetin and polycystic ovary syndrome
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Polycystic ovary syndrome and infertility: an update
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- Delayed Puberty
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Recommendations of endocrine treatment for patients with gender dysphoria
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Steroid Hormones of Reproduction and Sexual Development
- Is dehydroepiandrosterone a hormone?
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Redefining hormone resistance in prostate cancer
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Gender-Affirming Hormone Therapy for Transgender Men
- Hormones
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- The role of androgens in hormone replacement therapy
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- MENSTRUAL DISORDERS IN ADOLESCENTS